Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

McKesson Corporation : McKesson wins new two-year Veterans Affairs contract

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/12/2012 | 01:02am CET

Pharmaceutical wholesaler McKesson Corp on Wednesday said it was selected by the U.S. Department of Veterans Affairs to continue as the VA's prime pharmaceutical supplier for at least two more years.

News of the contract, which includes options for up to three two-year extensions, sent shares of McKesson up more than 4 percent in after hours trading.

The new agreement, valued by the VA at over $31.6 billion, calls for McKesson to supply all of the VA's more than 700 medical centers and outpatient clinics, as well as its seven consolidated mail outpatient pharmacies.

"Over the past eight years, McKesson has partnered with the VA to serve the healthcare needs of America's veterans," Paul Julian, the company's executive vice president and group president, said in a statement.

The VA, which estimated savings of about $3.26 billion through the life of the contract, said the new agreement goes into effect on May 10.

Shares of McKesson, which closed at $87.90 on the New York Stock Exchange, were trading at $91.89 after hours.

(Reporting By Deena Beasley, editing by M.D. Golan)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MCKESSON CORPORATION
02/17 MCKESSON CORP : Creation of a Direct Financial Obligation or an Obligation under..
02/16 MCKESSON : Value-based Care Services Provider, ACO Partner, Gains Traction in Ar..
02/14 MCKESSON : Wake County EMS Selects McKesson
02/13 MCKESSON : PharmaSmart and McKesson Pharmacy Systems Advance Outcome-Based Clini..
02/08 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involvin..
02/07 MCKESSON : Oregon Advanced Imaging Selects McKesson for Revenue Cycle Management
02/06 LAWSUIT FOR LONG-TERM INVESTORS IN S : MCK) Against Certain Directors over Alleg..
02/06 MCKESSON : Value-based Care Services Provider, ACO Partner, Gains Traction in Ar..
02/02 INVESTIGATION FOR INVESTORS IN SHARE : MCK) Announced
02/02 MCKESSON : Services Stocks on Investors' Radar -- Cardinal Health, AmerisourceBe..
More news
Sector news : Drug Retailers - NEC
02/16DJRetail CEOs Meet With Trump Over Border Tax Concerns -- Update
02/15DJRetail CEOs Meet With Trump Over Border Tax Concerns
02/14DJEXPRESS SCRIPTS : Revenue Falls
02/14 Exclusive - Trump to meet with retail CEOs on taxes, infrastructure
02/09DJCVS HEALTH : Profit Rises, Helped by Pharmacy Strength -- Update
More sector news : Drug Retailers - NEC
News from SeekingAlpha
02/16 Tracking Seth Klarman's Baupost Group Holdings - Q4 2016 Update
02/13 IBB : Merck Joins The Drug Pricing Coalition For Transparency
02/09 VALUATION DASHBOARD : Healthcare - Update
02/01 WEITZ VALUE FUND Q4 2016 COMMENTARY : Returns Hit By Liberty; Gains On Wells Far..
01/30 McKesson Corporation - Minor Losses May Be In Store
Advertisement
Financials ($)
Sales 2017 199 603 M
EBIT 2017 4 052 M
Net income 2017 2 311 M
Debt 2017 5 818 M
Yield 2017 0,75%
P/E ratio 2017 14,89
P/E ratio 2018 15,58
EV / Sales 2017 0,19x
EV / Sales 2018 0,18x
Capitalization 31 861 M
More Financials
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 155 $
Spread / Average Target 3,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
James A. Beer Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
Wayne A. Budd Independent Director
M. Christine Jacobs Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION6.98%31 861
WALGREENS BOOTS ALLIAN..3.75%92 678
CVS HEALTH CORP0.99%81 738
EXPRESS SCRIPTS HOLDIN..1.72%42 382
CARDINAL HEALTH INC12.14%25 460
AMERISOURCEBERGEN CORP..16.08%19 720
More Results